Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.64 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.64 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.57 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.57 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.57 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.57 |
| ▸ | PKN1 | Q16512 | 1/20 | 0.57 |
| ▸ | PKN2 | Q16513 | 1/20 | 0.57 |
| ▸ | METAP2 | P50579 | 1/20 | 0.56 |
| ▸ | METAP1 | P53582 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.54 |
| ▸ | RAB9A | P51151 | 4/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | CHEK2 | O96017 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 4/20 | 0.53 |
| ▸ | POLB | P06746 | 3/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20550742 | 0.89 | ALOX5 (0.53) | ALOX5EPHX2CHEK1LIMK1CDK5 | |
| SCHEMBL5488987 | 0.82 | METAP2 (0.47) | ALOX5EPHX2PKN1PKN2METAP2 | |
| SCHEMBL12082439 | 0.81 | ALOX5 (0.69) | ALOX5EPHX2CHEK1LIMK1CDK5 | |
| SCHEMBL8603371 | 0.81 | ALOX5 (0.73) | ALOX5EPHX2CHEK1LIMK1CDK5 | |
| SCHEMBL10758216 | 0.78 | ALOX5 (1.00) | ALOX5EPHX2CHEK1LIMK1CDK5 | |
| SCHEMBL20982510 | 0.77 | PKN1 (0.82) | PKN1PKN2METAP2METAP1ALDH1A1 | |
| SCHEMBL18764054 | 0.77 | CHEK2 (0.78) | PKN1PKN2METAP2METAP1ALDH1A1 | |
| SCHEMBL13185303 | 0.76 | PKN1 (0.54) | PKN1PKN2METAP2METAP1ALDH1A1 | |
| SCHEMBL13185225 | 0.76 | CHEK2 (0.60) | PKN1PKN2METAP2METAP1CHEK2 | |
| Fuberidazole SCHEMBL23174 | 0.76 | ALOX5 (0.65) | ALOX5EPHX2CHEK1LIMK1CDK5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180317484-A1 | COMPOSITION FOR INHIBITING SYNTHESIS OF MYCOTOXIN WITHOUT AFFECTING THE GROWTH OF THE FUNGI | VIT UNIVERSITY (IN) | 2018-11-08 | — | — | US | claimed |
| US-20180317484-A1 | COMPOSITION FOR INHIBITING SYNTHESIS OF MYCOTOXIN WITHOUT AFFECTING THE GROWTH OF THE FUNGI | VIT UNIVERSITY (IN) | 2018-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180317484-A1 | COMPOSITION FOR INHIBITING SYNTHESIS OF MYCOTOXIN WITHOUT AFFECTING THE GROWTH OF THE FUNGI | NAT1, AKR7A2, CYC1 | ALOX5 374/4885EPHX2 1670/4885CHEK1 1668/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.